Logo image of BRVO.CA

BRAVO MINING CORP (BRVO.CA) Stock Fundamental Analysis

TSX-V:BRVO - TSX Venture Exchange - CA10566M1068 - Common Stock - Currency: CAD

2.26  +0.01 (+0.44%)

Fundamental Rating

2

Taking everything into account, BRVO scores 2 out of 10 in our fundamental rating. BRVO was compared to 802 industry peers in the Metals & Mining industry. BRVO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BRVO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BRVO has reported negative net income.
In the past year BRVO has reported a negative cash flow from operations.
BRVO.CA Yearly Net Income VS EBIT VS OCF VS FCFBRVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

With a decent Return On Assets value of -4.02%, BRVO is doing good in the industry, outperforming 74.81% of the companies in the same industry.
With a decent Return On Equity value of -4.11%, BRVO is doing good in the industry, outperforming 77.31% of the companies in the same industry.
Industry RankSector Rank
ROA -4.02%
ROE -4.11%
ROIC N/A
ROA(3y)-5.74%
ROA(5y)N/A
ROE(3y)-5.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRVO.CA Yearly ROA, ROE, ROICBRVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -2 -4 -6 -8

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BRVO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRVO.CA Yearly Profit, Operating, Gross MarginsBRVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

5

2. Health

2.1 Basic Checks

The number of shares outstanding for BRVO has been increased compared to 1 year ago.
The debt/assets ratio for BRVO is higher compared to a year ago.
BRVO.CA Yearly Shares OutstandingBRVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRVO.CA Yearly Total Debt VS Total AssetsBRVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

BRVO has an Altman-Z score of 92.72. This indicates that BRVO is financially healthy and has little risk of bankruptcy at the moment.
BRVO has a Altman-Z score of 92.72. This is amongst the best in the industry. BRVO outperforms 94.39% of its industry peers.
BRVO has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.01, BRVO perfoms like the industry average, outperforming 51.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 92.72
ROIC/WACCN/A
WACCN/A
BRVO.CA Yearly LT Debt VS Equity VS FCFBRVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 30.14 indicates that BRVO has no problem at all paying its short term obligations.
BRVO's Current ratio of 30.14 is amongst the best of the industry. BRVO outperforms 94.89% of its industry peers.
A Quick Ratio of 30.14 indicates that BRVO has no problem at all paying its short term obligations.
BRVO has a better Quick ratio (30.14) than 94.89% of its industry peers.
Industry RankSector Rank
Current Ratio 30.14
Quick Ratio 30.14
BRVO.CA Yearly Current Assets VS Current LiabilitesBRVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.15% over the past year.
EPS 1Y (TTM)18.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-312.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 111.58% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-102%
EPS Next 2Y-58.9%
EPS Next 3YN/A
EPS Next 5Y111.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRVO.CA Yearly Revenue VS EstimatesBRVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2030 50M 100M 150M 200M
BRVO.CA Yearly EPS VS EstimatesBRVO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2028 2029 2030 0 0.1 0.2 0.3 0.4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRVO. In the last year negative earnings were reported.
Also next year BRVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRVO.CA Price Earnings VS Forward Price EarningsBRVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRVO.CA Per share dataBRVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

A cheap valuation may be justified as BRVO's earnings are expected to decrease with -58.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-58.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BRVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRAVO MINING CORP

TSX-V:BRVO (5/8/2025, 7:00:00 PM)

2.26

+0.01 (+0.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-08 2025-04-08/amc
Earnings (Next)05-16 2025-05-16
Inst Owners13.74%
Inst Owner ChangeN/A
Ins Owners53.22%
Ins Owner ChangeN/A
Market Cap246.66M
Analysts80
Price Target5.15 (127.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-33.33%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.16
P/tB 3.16
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.72
TBVpS0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.02%
ROE -4.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.74%
ROA(5y)N/A
ROE(3y)-5.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35980.5%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 30.14
Quick Ratio 30.14
Altman-Z 92.72
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)118475%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-312.5%
EPS Next Y-102%
EPS Next 2Y-58.9%
EPS Next 3YN/A
EPS Next 5Y111.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.83%
EBIT Next 3YN/A
EBIT Next 5Y103.76%
FCF growth 1Y41.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y54.32%
OCF growth 3YN/A
OCF growth 5YN/A